Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBROXOL vs AMIFAMPRIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBROXOL vs AMIFAMPRIDINE: Safety Overview

Metric AMBROXOL AMIFAMPRIDINE
Total FAERS Reports 906 2,424
Deaths Reported 55 203
Death Rate 6.1% 8.4%
Hospitalizations 441 680
Average Patient Age 57.8 yrs 62.5 yrs
% Female Patients 53.0% 62.6%
FDA Approval Date N/A Nov 28, 2018
Manufacturer N/A Catalyst Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription